(688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 688578 · · 13 pages · Chinese
Shanghai Allist Pharmaceuticals Co. Ltd. on 6ix
Earlier from Shanghai Allist Pharmaceuticals
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Voluntary Disclosure of FDA Approval of the Clinical Trial Application for AST1001 for Injection
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Initial Repurchase of Shares through Call Auction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Share Repurchase Plan through Call Auction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Resolutions of the 5th Meeting of the 3rd Board of Directors
Later from Shanghai Allist Pharmaceuticals
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Progress in Repurchasing Shares through Call Auction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Resignation of Board Secretary and Designation of the Chairman to Act as the Board Secretary
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Attending the Q3 2026 Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Progress in the Arbitration Matters
Follow Shanghai Allist Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Allist Pharmaceuticals